Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2018 | The NCRI Living with and Beyond Cancer Initiative

Galina Velikova • 16 Nov 2018
NCRI 2018
General

Galina Velikova, PhD, of the University of Leeds, Leeds, UK, speaks on the importance of outlining the top ten research priorities that have been set by the Living with and Beyond Cancer Initiative in order to engage patients, healthcare professionals and the general public. Prof. Velikova highlights the numerous issues related to the care of patients with cancer the list of research priorities aims to tackle. This video was recorded at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.

More from Galina Velikova

Late chemotherapy and endocrine therapy toxicities
1:17
Late chemotherapy and endocrine therapy toxicities
Galina Velikova • 3 May 2022
eRAPID: electronic self-reporting of adverse events for patients undergoing cancer treatment
1:18
eRAPID: electronic self-reporting of adverse events for patients undergoing cancer treatment
Galina Velikova • 3 May 2022
eRAPID improves patient self-management of cancer treatment side-effects
1:26
eRAPID improves patient self-management of cancer treatment side-effects
Galina Velikova • 3 May 2022
Sexual dysfunction among breast cancer survivors
1:09
Sexual dysfunction among breast cancer survivors
Galina Velikova • 3 May 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals